Ep 14 - A Conversation with John Mumm (Deka Biosciences)

John Mumm brings over 20 years of experience in academia and the biotechnology/pharmaceutical industry, having held positions of increasing responsibility. His primary focus has been on discovery research at the interface between cancer biology and the adaptive immune response. John has significant expertise in understanding what tumors secrete that negatively impacts the immune response and developing therapeutic strategies to overcome these barriers.

 

He has accumulated substantial experience in translational research, particularly in rendering cytokines into therapeutic entities. Recently, John has directed his efforts toward the manufacturing of biologics for Phase 1 and 2 immuno-oncology clinical trials. His specialties include Discovery Research, Biologics Manufacturing, Oncology: Immune Interface, Cytokine Biology, and Translational Research.